© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Health Catalyst, Inc. (HCAT) shows an Average True Range (ATR) of 0.14 and an Enterprise Value of 495.93M. Its average trading volume over the past 3 months is 768.39K, indicating liquidity. These fundamental metrics provide insight into HCAT's underlying financial health and market activity.
| ATR | 0.14 |
| Enterprise Value | 495.93M |
| Avg Vol (3 Months) | 768.39K |
| Avg Vol (10 Days) | 860.99K |
Health Catalyst, Inc. (HCAT) technical indicators as of March 10, 2026: the SMA 20 is -10.74%, SMA 50 at -20.4%, and SMA 200 at -42.39%. The RSI 14 value is 35.22, suggesting its current momentum. These technical analysis signals help assess HCAT's price trends and potential future movements.
| SMA 20 | -10.74% |
| SMA 50 | -20.4% |
| SMA 200 | -42.39% |
| RSI 14 | 35.22 |
Health Catalyst, Inc. (HCAT) stock performance overview as of March 10, 2026: The 52-week high is $5.06 (currently -65.62% below), and the 52-week low is $1.56 (currently 4.79% above). Over the past year, HCAT's performance is -59.82%, compared to the S&P 500's 17.64% change.
| 52-Week High | 5.06 |
| 52-Week High Chg | -65.62% |
| 52-Week Low | 1.56 |
| 52-Week Low Chg | +4.79% |
| S&P 500 52-Week Chg | 17.64% |
According to market data, Health Catalyst, Inc. (HCAT) stock's recent performance metrics show that over the last month, HCAT is -7.53%, with a Year-to-Date (YTD) performance of -7.53%. Over the past year, the stock has seen a -59.82% change. These figures summarize HCAT's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 1.96 | 2.2 | 2.88 | 3.62 | 5.06 | 2.51 |
| Low | 1.56 | 1.56 | 1.56 | 1.56 | 1.56 | 1.56 |
| Performance | -10.16% | -7.53% | -27.54% | -42.89% | -59.82% | -7.53% |
According to current financial data, HCAT stock's P/E (TTM) ratio is -1.19, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for HCAT, including P/S (0.41), P/B (0.38), and P/FCF (-5.63), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | HCAT | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -1.19 | -1.23 | 14.43 | 32.59 |
| P/S (TTM) | 0.41 | 3.71 | 8.3 | 5.98 |
| P/B (TTM) | 0.38 | 4.42 | 4.04 | 4.76 |
| P/FCF (TTM) | -5.63 | -8.35 | 10.04 | 33.08 |